Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Borgmann

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Scientific Reports|November 4, 2020
The POLD1<sup>R689W</sup> variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitorsAlbert Job, Marina Tatura, Cora Schäfer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2008
The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repairUlla Kasten-Pisula, Apostolos Menegakis, Ingo Brammer, et al.
Oncotarget|January 23, 2016
PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation responseStephanie Wurster, Fabian Hennes, Ann C Parplys, et al.
Cells|January 23, 2020
Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast CancerFelix Meyer, Saskia Becker, Sandra Classen, et al.
Experimental Hematology|October 14, 2010
Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cellsUte Brassat, Stefan Balabanov, Daniel Bali, et al.
Cell Cycle (Georgetown, Tex.)|August 29, 2015
High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activationAnn Christin Parplys, Jasna Irena Seelbach, Saskia Becker, et al.
Cell Reports|June 20, 2019
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor SensitivityLynnette Marcar, Kankana Bardhan, Liliana Gheorghiu, et al.
Scientific Reports|February 12, 2021
Targeting the DNA replication stress phenotype of KRAS mutant cancer cellsTara Al Zubaidi, O H Fiete Gehrisch, Marie-Michelle Genois, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2022
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinomaMara Borgmann, Agnes Oetting, Felix Meyer, et al.
International Journal of Molecular Sciences|November 11, 2022
Partial Reduction in <i>BRCA1</i> Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or ResistanceSandra Classen, Elena Rahlf, Johannes Jungwirth, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Scientific Reports|November 4, 2020
The POLD1<sup>R689W</sup> variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitorsAlbert Job, Marina Tatura, Cora Schäfer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2008
The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repairUlla Kasten-Pisula, Apostolos Menegakis, Ingo Brammer, et al.
Oncotarget|January 23, 2016
PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation responseStephanie Wurster, Fabian Hennes, Ann C Parplys, et al.
Cells|January 23, 2020
Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast CancerFelix Meyer, Saskia Becker, Sandra Classen, et al.
Experimental Hematology|October 14, 2010
Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cellsUte Brassat, Stefan Balabanov, Daniel Bali, et al.
Cell Cycle (Georgetown, Tex.)|August 29, 2015
High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activationAnn Christin Parplys, Jasna Irena Seelbach, Saskia Becker, et al.
Cell Reports|June 20, 2019
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor SensitivityLynnette Marcar, Kankana Bardhan, Liliana Gheorghiu, et al.
Scientific Reports|February 12, 2021
Targeting the DNA replication stress phenotype of KRAS mutant cancer cellsTara Al Zubaidi, O H Fiete Gehrisch, Marie-Michelle Genois, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2022
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinomaMara Borgmann, Agnes Oetting, Felix Meyer, et al.
International Journal of Molecular Sciences|November 11, 2022
Partial Reduction in <i>BRCA1</i> Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or ResistanceSandra Classen, Elena Rahlf, Johannes Jungwirth, et al.
Pageof 9